AAAAAA
Results:
1-18
|
Results: 18
Authors:
SPRIGGS DR
MAKHIJA S
Citation: Dr. Spriggs et S. Makhija, OVARIAN-CANCER STAGING - TIME FOR A CLOSER LOOK, Journal of clinical oncology, 16(8), 1998, pp. 2577-2578
Authors:
AGHAJANIAN C
FENNELLY D
SHAPIRO F
WALTZMAN R
ALMADRONES L
OFLAHERTY C
OCONNER K
VENKATRAMAN E
BARAKAT R
CURTIN J
BROWN C
REICH L
WUEST D
NORTON L
HOSKINS W
SPRIGGS DR
Citation: C. Aghajanian et al., PHASE-II STUDY OF DOSE-DENSE HIGH-DOSE CHEMOTHERAPY TREATMENT WITH PERIPHERAL-BLOOD PROGENITOR-CELL SUPPORT AS PRIMARY-TREATMENT FOR PATIENTS WITH ADVANCED OVARIAN-CANCER, Journal of clinical oncology, 16(5), 1998, pp. 1852-1860
Authors:
BERNSTEIN DI
SMITH VE
SHERWOOD JR
SCHIFF GM
SANDER DS
DEFEUDIS D
SPRIGGS DR
WARD RL
Citation: Di. Bernstein et al., SAFETY AND IMMUNOGENICITY OF LIVE, ATTENUATED HUMAN ROTAVIRUS VACCINE-89-12, Vaccine, 16(4), 1998, pp. 381-387
Authors:
HUSAIN A
APTAKER L
SPRIGGS DR
BARAKAT RR
Citation: A. Husain et al., GASTROINTESTINAL TOXICITY AND CLOSTRIDIUM-DIFFICILE DIARRHEA IN PATIENTS TREATED WITH PACLITAXEL-CONTAINING CHEMOTHERAPY REGIMENS, Gynecologic oncology (Print), 71(1), 1998, pp. 104-107
Authors:
HUSAIN A
ROSALES N
SCHWARTZ GK
SPRIGGS DR
Citation: A. Husain et al., LISOFYLLINE SENSITIZES P53 MUTANT HUMAN OVARIAN-CARCINOMA CELLS TO THE CYTOTOXIC EFFECTS OF CIS-DIAMMINEDICHLOROPLATINUM(II), Gynecologic oncology (Print), 70(1), 1998, pp. 17-22
Authors:
HUSAIN A
HE GS
VENKATRAMAN ES
SPRIGGS DR
Citation: A. Husain et al., BRCA1 UP-REGULATION IS ASSOCIATED WITH REPAIR-MEDIATED RESISTANCE TO CIS-DIAMMINEDICHLOROPLATINUM(II), Cancer research, 58(6), 1998, pp. 1120-1123
Authors:
HUSAIN A
YAN XJ
ROSALES N
AGHAJANIAN C
SCHWARTZ GK
SPRIGGS DR
Citation: A. Husain et al., UCN-01 IN OVARY CANCER-CELLS - EFFECTIVE AS A SINGLE-AGENT AND IN COMBINATION WITH CIS-DIAMMINEDICHLOROPLATINUM(II) INDEPENDENT OF P53 STATUS, Clinical cancer research, 3(11), 1997, pp. 2089-2097
Authors:
FENNELLY DW
AGHAJANIAN C
SHAPIRO F
OFLAHERTY C
OCONNOR K
CURTIN JP
CROWN JP
HOSKINS WJ
SPRIGGS DR
Citation: Dw. Fennelly et al., DOSE-ESCALATION OF PACLITAXEL WITH HIGH-DOSE CARBOPLATIN USING PERIPHERAL-BLOOD PROGENITOR-CELL SUPPORT IN PATIENTS WITH ADVANCED OVARIAN-CANCER, Seminars in oncology, 24(1), 1997, pp. 26-30
Authors:
AGHAJANIAN C
BROWN C
OFLAHERTY C
FLEISCHAUER A
CURTIN J
VONROEMELING R
SPRIGGS DR
Citation: C. Aghajanian et al., PHASE-I STUDY OF TIRAPAZAMINE AND CISPLATIN IN PATIENTS WITH RECURRENT CERVICAL-CANCER, Gynecologic oncology, 67(2), 1997, pp. 127-130
Authors:
WANG EH
MA WJ
AGHAJANIAN C
SPRIGGS DR
Citation: Eh. Wang et al., POSTTRANSCRIPTIONAL REGULATION OF PROTEIN EXPRESSION IN HUMAN EPITHELIAL CARCINOMA-CELLS BY ADENINE-URIDINE-RICH ELEMENTS IN THE 3'-UNTRANSLATED REGION OF TUMOR-NECROSIS-FACTOR-ALPHA MESSENGER-RNA, Cancer research, 57(23), 1997, pp. 5426-5433
Authors:
ROBERTS JA
KUDELKA AP
SPRIGGS DR
MUGGIA F
LURAIN J
GROVE W
KOWAL C
Citation: Ja. Roberts et al., A PHASE-2 STUDY OF CISPLATIN ANALOG CI-973 IN THE TREATMENT OF PATIENTS WITH REFRACTORY, ADVANCED OVARIAN-CANCER, International journal of gynecological cancer, 6(4), 1996, pp. 257-260
Authors:
GOGAS H
SHAPIRO F
AGHAJANIAN C
FENNELLY D
ALMADRONES L
HOSKINS WJ
SPRIGGS DR
Citation: H. Gogas et al., THE IMPACT OF DIABETES-MELLITUS ON THE TOXICITY OF THERAPY FOR ADVANCED OVARIAN-CANCER, Gynecologic oncology, 61(1), 1996, pp. 22-26
Authors:
SAKATA M
CHANEY SG
SPRIGGS DR
Citation: M. Sakata et al., POSSIBLE CORRELATION BETWEEN ORMAPLATIN BIOTRANSFORMATIONS AND NEUROTOXICITY, Oncology research, 7(2), 1995, pp. 67-71
Authors:
ROBINS HI
DOLEIRE F
KUTZ M
BIRD A
SCHMITTTIGGELAAR CL
COHEN JD
SPRIGGS DR
Citation: Hi. Robins et al., CYTOTOXIC INTERACTIONS OF TUMOR-NECROSIS-FACTOR, MELPHALAN AND 41.8-DEGREES-C HYPERTHERMIA, Cancer letters, 89(1), 1995, pp. 55-62
Authors:
COSTER TS
KILLEEN KP
WALDOR MK
BEATTIE DT
SPRIGGS DR
KENNER JR
TROFA A
SADOFF JC
MEKALANOS JJ
TAYLOR DN
Citation: Ts. Coster et al., SAFETY, IMMUNOGENICITY, AND EFFICACY OF LIVE ATTENUATED VIBRIO-CHOLERAE O139 VACCINE PROTOTYPE, Lancet, 345(8955), 1995, pp. 949-952
Authors:
KENNER JR
COSTER TS
TAYLOR DN
TROFA AF
BARRERAORO M
HYMAN T
ADAMS JM
BEATTIE DT
KILLEEN KP
SPRIGGS DR
MEKALANOS JJ
SADOFF JC
Citation: Jr. Kenner et al., PERU-15, AN IMPROVED LIVE ATTENUATED ORAL VACCINE CANDIDATE FOR VIBRIO-CHOLERAE-01, The Journal of infectious diseases, 172(4), 1995, pp. 1126-1129
Authors:
BAILEY HH
MULCAHY RT
TUTSCH KD
ARZOOMANIAN RZ
ALBERTI D
TOMBES MB
WILDING G
POMPLUN M
SPRIGGS DR
Citation: Hh. Bailey et al., PHASE-I CLINICAL-TRIAL OF INTRAVENOUS L-BUTHIONINE SULFOXIMINE AND MELPHALAN - AN ATTEMPT AT MODULATION OF GLUTATHIONE, Journal of clinical oncology, 12(1), 1994, pp. 194-205
Authors:
RAGO RP
MILES JM
SUFIT RL
SPRIGGS DR
WILDING G
Citation: Rp. Rago et al., SURAMIN-INDUCED WEAKNESS FROM HYPOPHOSPHATEMIA AND MITOCHONDRIAL MYOPATHY - ASSOCIATION OF SURAMIN WITH MITOCHONDRIAL TOXICITY IN HUMANS, Cancer, 73(7), 1994, pp. 1954-1959
Risultati:
1-18
|